US5080645A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Procedure for reducing the body burden of HIV (AIDS) and other blood borne infections
Assignee: Individual
•
Filing: 1989-10-31
•
Granted: 1992-01-14
•
Expires: 2009-10-31
Abstract
Abstract The foregoing emergency replacement procedure or method for rapid and drastic reduction of the body burden of AIDS virus residing primarily in the formed elements of the blood involves the removal of all blood from the patient and replacement with an emulsion of a perfluorocarbon chemical or other blood substitute, several exchanges of blood substitute in order to attempt a "scrubbing" in totality of the AIDS containing blood from all of the tissues and organs served by vascular beds and then replacement of the emulsion of perfluorocarbon chemical or other blood substitute with whole blood of the same type as the patient; and wherein the above replacement procedure is carried out using antiviral agents or other agents currently shown to reduce, mitigate or destroy the AIDS virus during and after the above said replacement procedure.
Inventors
- 👤 Joseph P. Hanig
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:57
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M2202/00; A61M2202/04; A61M2202/0468; A61M2202/0476
Claims Analysis
Total Claims: 29
Claim 1
Independent Claim
66 words
A method for reducing the body burden of a blood borne infection in a patient comprising the steps of: A) substantially or completely replacing the blood of a patient having a blood born infection with a synthetic blood substitute, and as part of a continuous process; B) subsequently replacing said synthetic blood substitute with whole blood, thereby reducing the number of infected cells in said patient.
Claim 2
Independent Claim
66 words
A method for reducing the body burden of a blood borne infection in a patient comprising the steps of: A) substantially or completely replacing the blood of a patient having a blood born infection with a synthetic blood substitute, and as part of a continuous process; B) subsequently replacing said synthetic blood substitute with whole blood, thereby reducing the number of infected cells in said patient.
Claim 3
Dependent Claim
35 words
The method of claim 1, wherein after step A but before step B, said synthetic blood substitute is partially or substantially completely replaced one or more times with additional quantities of a synthetic blood substitute.
Claim 4
Dependent Claim
28 words
The method of claim 1, wherein steps A and B are carried out under clinical cryogenic conditions of lowered body temperature which reduce the patient's need for oxygen.
Claim 5
Dependent Claim
21 words
The method of claim 1, wherein steps A and B are carried out under conditions of supplemented oxygen up to 100%.
Claim 6
Dependent Claim
18 words
The method of claim 1, wherein steps A and B are carried out under conditions of hyperbaric pressure.
Claim 7
Dependent Claim
18 words
The method of claim 1, wherein steps A and B are carried out as rapidly as clinically possible.
Claim 8
Dependent Claim
37 words
The method of claim 1, wherein at least one therapeutic agent for said blood born infection is administered to said patient in said synthetic blood substitute, concurrently with said synthetic blood substitute, or subsequent to step B.
Claim 9
Dependent Claim
14 words
The method of claim 1, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 10
Dependent Claim
15 words
The method of claim 1, wherein said synthetic blood substitute comprises a synthetic hemoglobin substitute.
Claim 11
Independent Claim
61 words
A method for reducing the body burden of AIDS virus in a patient having AIDS comprising the steps of: A) substantially or completely replacing the blood of an AIDS patient with a synthetic blood substitute, and as part of a continuous process; B) replacing said synthetic blood substitute with whole blood, thereby reducing the number of infected cells in said patient.
Claim 12
Independent Claim
61 words
A method for reducing the body burden of AIDS virus in a patient having AIDS comprising the steps of: A) substantially or completely replacing the blood of an AIDS patient with a synthetic blood substitute, and as part of a continuous process; B) replacing said synthetic blood substitute with whole blood, thereby reducing the number of infected cells in said patient.
Claim 13
Dependent Claim
35 words
The method of claim 10, wherein after step A but before step B, said synthetic blood substitute is partially or substantially completely replaced one or more times with additional quantities of a synthetic blood substitute.
Claim 14
Dependent Claim
28 words
The method of claim 10, wherein steps A and B are carried out under clinical cryogenic conditions of lowered body temperature which reduce the patient's need for oxygen.
Claim 15
Dependent Claim
21 words
The method of claim 10, wherein steps A and B are carried out under conditions of supplemented oxygen up to 100%.
Claim 16
Dependent Claim
18 words
The method of claim 10, wherein steps A and B are carried out under conditions of hyperbaric pressure.
Claim 17
Dependent Claim
18 words
The method of claim 10, wherein steps A and B are carried out as rapidly as clinically possible.
Claim 18
Dependent Claim
36 words
The method of claim 10, wherein at least one therapeutic agent for said AIDS infection is administered to said patient in said synthetic blood substitute, concurrently with said synthetic blood substitute, or subsequent to step B.
Claim 19
Dependent Claim
15 words
The method according to claim 10, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 20
Dependent Claim
15 words
The method according to claim 11, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 21
Dependent Claim
15 words
The method according to claim 12, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 22
Dependent Claim
15 words
The method according to claim 13, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 23
Dependent Claim
15 words
The method according to claim 14, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 24
Dependent Claim
15 words
The method according to claim 15, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 25
Dependent Claim
15 words
The method according to claim 16, wherein said synthetic blood substitute comprises a perfluorocarbon compound.
Claim 26
Dependent Claim
15 words
The method of claim 10, wherein said synthetic blood substitute comprises a synthetic hemoglobin substitute.
Claim 27
Dependent Claim
15 words
The method of claim 11, wherein said synthetic blood substitute comprises a synthetic hemoglobin substitute.
Claim 28
Dependent Claim
15 words
The method of claim 12, wherein said synthetic blood substitute comprises a synthetic hemoglobin substitute.
Claim 29
Dependent Claim
15 words
The method of claim 13, wherein said synthetic blood substitute comprises a synthetic hemoglobin substitute.
References Cited (Backward Citations)
US4824432A
Cited
US4846789A
Cited
US4520109A
Cited
US4737140A
Cited
US4931472A
Cited
US4787883A
Cited
US4772840A
Cited
US4878891A
Cited
US4833165A
Cited
US4865841A
Cited
US4923442A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-01-13 | 1995-07-15 | 1996-01-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-01-13 | 1999-07-15 | 2000-01-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-01-13 | 2003-07-15 | 2004-01-14 | $7700.00 | Window Closed / Lapsed |